Wider patient access to CGTs hinges on further infrastructure developments and the movement of therapies into the community setting.

AbbVie's Rinvoq, Pfizer and BioNTech's Comirnaty and Incyte's Opzelura have all received their own EU drug regulatory approvals this week.

An unlicensed semaglutide-based product that is administered under the tongue is being marketed to private doctors in the UK despite the branded medicine’s manufacturer warning of safety concerns.

J&J strikes its deal with Sail as the in vivo CAR-T space becomes increasingly crowded, with several big pharma players betting on the class.

Covid-19 has created a perfect storm for cybercrime, giving hackers both the means and the motivation to step up their criminal activities. Credit: Getty Images At the start of the Covid-19 pandemic, ...

In a lawsuit filed in the US, Novo alleged that Lilly’s campaign was designed to mislead consumers on “comparative efficacy” of drug brands.

Recule has signed a research collaboration with Rio Biofarma Brasil (RBBL) to co-develop peptide-mediated delivery technologies aimed at improving targeted RNA therapeutics delivery to tissues beyond ...

Regenerative medicine offers an innovative approach to treating different indications by restoring damaged or diseased cells and tissues.

BMS enhances its AI computing power with NVIDIA's DGX SuperPOD as big pharma race to stay competitive within the shifting global landscape.

Despite a lacklustre start to the year, Novartis seems to have overcome its financial slump, reporting operating profits in Q2 that exceeded analyst expectations. The Swiss drugma ...

Synlogic and Caldera Therapeutics have signed a definitive merger agreement aimed at combining in an all-stock transaction.

Resilience and Lilly have invested $750m to boost production of Lilly’s KwikPen to boost the US supply of diabetes and obesity medicines.